info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
N-Nitroso Enzalutamide Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142371 |
| CAS No | NA |
| Mol.F. | C11H10FN5O4 |
| Mol.Wt. | 295.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142372 |
| CAS No | NA |
| Mol.F. | C5H10N4O4 |
| Mol.Wt. | 190.16 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142373 |
| CAS No | NA |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.21 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142374 |
| CAS No | NA |
| Mol.F. | C20H25N3O |
| Mol.Wt. | 323 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142375 |
| CAS No | NA |
| Mol.F. | C15H14N2O |
| Mol.Wt. | 238 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142376 |
| CAS No | NA |
| Mol.F. | C23H36N8O6S |
| Mol.Wt. | 552.65 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142377 |
| CAS No | NA |
| Mol.F. | C22H33N5O6S |
| Mol.Wt. | 495.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142378 |
| CAS No | NA |
| Mol.F. | C9H16N2O3 |
| Mol.Wt. | 200.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142379 |
| CAS No | NA |
| Mol.F. | C23H34N6O7S |
| Mol.Wt. | 538.62 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142380 |
| CAS No | NA |
| Mol.F. | C7H12N2O3 |
| Mol.Wt. | 172.18 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142381 |
| CAS No | NA |
| Mol.F. | C16H24N6O5S |
| Mol.Wt. | 412.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142382 |
| CAS No | NA |
| Mol.F. | C33H45N9O9S2 |
| Mol.Wt. | 775.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142383 |
| CAS No | NA |
| Mol.F. | C9H16N2O3 |
| Mol.Wt. | 200.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142384 |
| CAS No | NA |
| Mol.F. | C25H39N7O6S |
| Mol.Wt. | 565.69 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142385 |
| CAS No | NA |
| Mol.F. | C10H12N2O4S |
| Mol.Wt. | 256.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142386 |
| CAS No | NA |
| Mol.F. | C13H18N2O5S |
| Mol.Wt. | 314.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
